![Safety and activity of varlilumab, a novel and first-in-class agonist anti- CD27 antibody, for hematologic malignancies - ScienceDirect Safety and activity of varlilumab, a novel and first-in-class agonist anti- CD27 antibody, for hematologic malignancies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2473952920313239-gr1.jpg)
Safety and activity of varlilumab, a novel and first-in-class agonist anti- CD27 antibody, for hematologic malignancies - ScienceDirect
![Conceptual diagram of CD27-CD70 complex within immunological synapse.... | Download Scientific Diagram Conceptual diagram of CD27-CD70 complex within immunological synapse.... | Download Scientific Diagram](https://www.researchgate.net/publication/354029069/figure/fig4/AS:1058871367983109@1629466015721/Conceptual-diagram-of-CD27-CD70-complex-within-immunological-synapse-A-Comparison-of.png)
Conceptual diagram of CD27-CD70 complex within immunological synapse.... | Download Scientific Diagram
![Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering | Communications Biology Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering | Communications Biology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs42003-022-03182-6/MediaObjects/42003_2022_3182_Fig1_HTML.png)
Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering | Communications Biology
![CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells | Communications Biology CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells | Communications Biology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs42003-020-1097-8/MediaObjects/42003_2020_1097_Fig5_HTML.png)
CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells | Communications Biology
![Targeting the T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy: rationale and potential | Immunotherapy Targeting the T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy: rationale and potential | Immunotherapy](https://www.futuremedicine.com/cms/10.2217/imt.15.32/asset/images/medium/figure2.gif)
Targeting the T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy: rationale and potential | Immunotherapy
![CD27 Monoclonal Antibody (LG.7F9), PE, eBioscience™, Invitrogen™ 100 μg; PE CD27 Monoclonal Antibody (LG.7F9), PE, eBioscience™, Invitrogen™ | Fisher Scientific CD27 Monoclonal Antibody (LG.7F9), PE, eBioscience™, Invitrogen™ 100 μg; PE CD27 Monoclonal Antibody (LG.7F9), PE, eBioscience™, Invitrogen™ | Fisher Scientific](https://assets.fishersci.com/TFS-Assets/LSG/figures/12-0271-82_CD27_Flow_1-20170119083539.jpg-650.jpg)
CD27 Monoclonal Antibody (LG.7F9), PE, eBioscience™, Invitrogen™ 100 μg; PE CD27 Monoclonal Antibody (LG.7F9), PE, eBioscience™, Invitrogen™ | Fisher Scientific
![Analysis of B cell phenotype on the basis of IgD and CD27 expression in... | Download Scientific Diagram Analysis of B cell phenotype on the basis of IgD and CD27 expression in... | Download Scientific Diagram](https://www.researchgate.net/publication/327650583/figure/fig2/AS:679857826570241@1539102145117/Analysis-of-B-cell-phenotype-on-the-basis-of-IgD-and-CD27-expression-in-the-blood-of-an.png)
Analysis of B cell phenotype on the basis of IgD and CD27 expression in... | Download Scientific Diagram
![Frontiers | Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation Frontiers | Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation](https://www.frontiersin.org/files/Articles/715909/fimmu-12-715909-HTML-r1/image_m/fimmu-12-715909-g002.jpg)
Frontiers | Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation
![The Interplay between CD27dull and CD27bright B Cells Ensures the Flexibility, Stability, and Resilience of Human B Cell Memory - ScienceDirect The Interplay between CD27dull and CD27bright B Cells Ensures the Flexibility, Stability, and Resilience of Human B Cell Memory - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124720301765-fx1.jpg)
The Interplay between CD27dull and CD27bright B Cells Ensures the Flexibility, Stability, and Resilience of Human B Cell Memory - ScienceDirect
![From “truly naïve” to “exhausted senescent” T cells: When markers predict functionality - Larbi - 2014 - Cytometry Part A - Wiley Online Library From “truly naïve” to “exhausted senescent” T cells: When markers predict functionality - Larbi - 2014 - Cytometry Part A - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ab79f693-62bb-4fbb-8374-abb695251497/cytoa22351-fig-0001-m.jpg)
From “truly naïve” to “exhausted senescent” T cells: When markers predict functionality - Larbi - 2014 - Cytometry Part A - Wiley Online Library
![The CD70-CD27 axis in oncology: the new kids on the block | Journal of Experimental & Clinical Cancer Research | Full Text The CD70-CD27 axis in oncology: the new kids on the block | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13046-021-02215-y/MediaObjects/13046_2021_2215_Fig1_HTML.png)
The CD70-CD27 axis in oncology: the new kids on the block | Journal of Experimental & Clinical Cancer Research | Full Text
![CD27−CD38+ B cells accumulated in early HIV infection exhibit transitional profile and promote HIV disease progression - ScienceDirect CD27−CD38+ B cells accumulated in early HIV infection exhibit transitional profile and promote HIV disease progression - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124721007208-gr1.jpg)
CD27−CD38+ B cells accumulated in early HIV infection exhibit transitional profile and promote HIV disease progression - ScienceDirect
![Targeting the T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy: rationale and potential | Immunotherapy Targeting the T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy: rationale and potential | Immunotherapy](https://www.futuremedicine.com/cms/10.2217/imt.15.32/asset/images/medium/figure1.gif)
Targeting the T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy: rationale and potential | Immunotherapy
![Double‐negative (DN) B cells: an under‐recognized effector memory B cell subset in autoimmunity - Li - 2021 - Clinical & Experimental Immunology - Wiley Online Library Double‐negative (DN) B cells: an under‐recognized effector memory B cell subset in autoimmunity - Li - 2021 - Clinical & Experimental Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/93d1a781-3690-4a97-b6ae-1bbae885ef6a/cei13615-fig-0001-m.jpg)